BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 26, 2025
See today's BioWorld MedTech
Home
» Amulyte takes Crowd Funding route to get device to market
To read the full story,
subscribe
or
sign in
.
Amulyte takes Crowd Funding route to get device to market
Oct. 16, 2013
By
Omar Ford
No Comments
So just what can a med-tech start-up do to secure funding in a time where venture capital investors are extremely conservative with investment dollars? Why go to Crowd Investing of course.
BioWorld MedTech